📊 Score Breakdown
Offering Ability
60
Cash Runway
65
Float Risk
12
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
10%
💰 Capital Raise
15%
• Under 12 months cash (9mo)
🔄 Reverse Split
10%
• 9 months cash with weak price
💹 Market Data
Market Cap$645.51M
Shares Outstanding104.45M
Float100.48M
Cash$219.89M
Debt$319.74M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 95.2% shares (2025Q4 vs prior)
4 institutional holders · 34.6K shares
#1
Altrafin AG
34.1K shares
#2
CHESAPEAKE ASSET MANAGEMENT LLC
550 shares
#3
Your Advocates Ltd., LLP
5 shares
+ 1 more holders Sign up free to view →
📉 Short Interest
Short Interest22.71M
Days to Cover2.5
% of Float22.6%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2023
4
INSIDER TRANSACTION
Apr 09, 2026
4
INSIDER TRANSACTION
Apr 09, 2026
4
INSIDER TRANSACTION
Apr 09, 2026
4
INSIDER TRANSACTION
Apr 09, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for SPCE
📊 SPCE FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 SPCE Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.